Urticaria and Angioedema
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
3628-3641-Pruritus in Selected Dermatoses
Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences 2016; 20: 3628-3641 Pruritus in selected dermatoses K. OLEK-HRAB 1, M. HRAB 2, J. SZYFTER-HARRIS 1, Z. ADAMSKI 1 1Department of Dermatology, University of Medical Sciences, Poznan, Poland 2Department of Urology, University of Medical Sciences, Poznan, Poland Abstract. – Pruritus is a natural defence mech - logical self-defence mechanism similar to other anism of the body and creates the scratch reflex skin sensations, such as touch, pain, vibration, as a defensive reaction to potentially dangerous cold or heat, enabling the protection of the skin environmental factors. Together with pain, pruritus from external factors. Pruritus is a frequent is a type of superficial sensory experience. Pruri - symptom associated with dermatoses and various tus is a symptom often experienced both in 1 healthy subjects and in those who have symptoms systemic diseases . Acute pruritus often develops of a disease. In dermatology, pruritus is a frequent simultaneously with urticarial symptoms or as an symptom associated with a number of dermatoses acute undesirable reaction to drugs. The treat - and is sometimes an auxiliary factor in the diag - ment of this form of pruritus is much easier. nostic process. Apart from histamine, the most The chronic pruritus that often develops in pa - popular pruritus mediators include tryptase, en - tients with cholestasis, kidney diseases or skin dothelins, substance P, bradykinin, prostaglandins diseases (e.g. atopic dermatitis) is often more dif - and acetylcholine. The group of atopic diseases is 2,3 characterized by the presence of very persistent ficult to treat . Persistent rubbing, scratching or pruritus. -
Urticaria - Primary Care Treatment Pathway
DORSET MEDICINES ADVISORY GROUP Urticaria - Primary Care Treatment Pathway Urticaria – also known as hives or nettle rash – is a raised, itchy rash that can occur on just one part of the body or be spread across large areas. The weals of urticaria last less than 24 hours although patients may develop new weals on a daily basis. If urticaria clears completely within six weeks, it is known as acute urticaria. Urticaria occurring for more than six weeks is referred to as chronic urticaria. Most cases of chronic disease occur without an obvious trigger (chronic spontaneous urticaria). Some urticaria has a physical trigger such as pressure (symptomatic dermographism or delayed pressure urticaria), cold or exercise (cholinergic urticaria), or may be drug induced (e.g. by NSAIDS, ACE inhibitors and opioids). All forms of urticaria can be treated with antihistamine although physical urticaria is less likely to respond to treatment than spontaneous urticaria. Most cases of urticaria settle spontaneously within two years but the condition can last for decades in some patients. Referral criteria Refer routinely to dermatology if patients are not responding to standard treatment (see primary care treatment below, up to step 4), they can then be considered for immunomodulation treatment such as ciclosporin (can be very useful for patients thought to have an autoimmune basis for their urticaria), methotrexate or omalizumab. The diagnosis of urticaria is primarily clinical therefore do not routinely refer for allergy testing. The British Association of Dermatologists (BAD) has produced a patient information leaflet which covers this in detail for patients. PRIOR TO SPECIALIST REFERRAL -conduct a full blood count (FBC), erythrocyte sedimentation rate (ESR), thyroid function tests (TFTs), liver function tests (LFTs), and Helicobacter pylori screening (if gastrointestinal symptoms are present). -
Urticaria from Wikipedia, the Free Encyclopedia Jump To: Navigation, Search "Hives" Redirects Here
Urticaria From Wikipedia, the free encyclopedia Jump to: navigation, search "Hives" redirects here. For other uses, see Hive. Urticaria Classification and external resourcesICD-10L50.ICD- 9708DiseasesDB13606MedlinePlus000845eMedicineemerg/628 MeSHD014581Urtic aria (or hives) is a skin condition, commonly caused by an allergic reaction, that is characterized by raised red skin wheals (welts). It is also known as nettle rash or uredo. Wheals from urticaria can appear anywhere on the body, including the face, lips, tongue, throat, and ears. The wheals may vary in size from about 5 mm (0.2 inches) in diameter to the size of a dinner plate; they typically itch severely, sting, or burn, and often have a pale border. Urticaria is generally caused by direct contact with an allergenic substance, or an immune response to food or some other allergen, but can also appear for other reasons, notably emotional stress. The rash can be triggered by quite innocent events, such as mere rubbing or exposure to cold. Contents [hide] * 1 Pathophysiology * 2 Differential diagnosis * 3 Types * 4 Related conditions * 5 Treatment and management o 5.1 Histamine antagonists o 5.2 Other o 5.3 Dietary * 6 See also * 7 References * 8 External links [edit] Pathophysiology Allergic urticaria on the shin induced by an antibiotic The skin lesions of urticarial disease are caused by an inflammatory reaction in the skin, causing leakage of capillaries in the dermis, and resulting in an edema which persists until the interstitial fluid is absorbed into the surrounding cells. Urticarial disease is thought to be caused by the release of histamine and other mediators of inflammation (cytokines) from cells in the skin. -
Information for Referrers: Chronic Urticaria
Fact Sheet Information for Referrers: Chronic Urticaria Chronic urticaria (CU) is defined by the presence of urticaria (wheals, hives) on most days of the week, for longer than six weeks. Angioedema occurs in about 40 percent of patients with CU and usually affects the lips, cheeks, periorbital areas, extremities, and genitals (seldom the tongue, throat or airway). In many cases, the underlying cause is autoimmunity (autoantibodies to the mast cell IgE receptor). Food allergy is almost never the cause. Chronic urticaria can cause marked distress because it is physically uncomfortable, waxes and wanes unpredictably, and may interfere with work/school and sleep. When to refer CU patients: > Where CU is not controlled by antihistamines or has persisted for more than 6 months. > Where there is concern patients are undertaking inappropriate dietary restrictions. > Where angioedema has involved the oropharyngeal or laryngeal areas. > Any features that might suggest an autoimmune or inflammatory disorder. > Where there are features to suggest urticarial vasculitis (lesions lasting >24 hours, burning rather than itching, residual bruising). > Where prednisolone has been needed repeatedly to control symptoms. Reassurance Patients with CU are often frustrated, and reassurance is an important component of successful management. There are three important concepts to relay to patients: > CU is usually transient, and 50 percent of patients undergo remission within one year. > While acute urticaria may be a manifestation of allergy and may be associated with anaphylaxis, chronic urticaria is a different disorder that is usually not allergic in origin and is not dangerous. > The symptoms of CU can be successfully managed in the majority of patients. -
The Health and Welfare of Australia's Aboriginal and Torres Strait Islander People: an Overview (Full Publication; 5 May
The health and welfare of Australia’s Aboriginal and Torres Strait Islander people an overview 2011 The Australian Institute of Health and Welfare is Australia’s national health and welfare statistics and information agency. The Institute’s mission is better information and statistics for better health and wellbeing. © Australian Institute of Health and Welfare 2011 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced without prior written permission from the Australian Institute of Health and Welfare. Requests and enquiries concerning reproduction and rights should be directed to the Head of the Communications, Media and Marketing Unit, Australian Institute of Health and Welfare, GPO Box 570, Canberra ACT 2601. A complete list of the Institute’s publications is available from the Institute’s website <www.aihw.gov.au>. ISBN 978 1 74249 148 6 Suggested citation Australian Institute of Health and Welfare 2011. The health and welfare of Australia’s Aboriginal and Torres Strait Islander people, an overview 2011. Cat. no. IHW 42. Canberra: AIHW. Australian Institute of Health and Welfare Board Chair Hon. Peter Collins, AM, QC Director David Kalisch Any enquiries about or comments on this publication should be directed to: Communication, Media and Marketing Unit Australian Institute of Health and Welfare GPO Box 570 Canberra ACT 2601 Phone: (02) 6244 1032 Email: [email protected] Published by the Australian Institute of Health and Welfare Printed by Paragon Printers Australasia Please note that there is the potential for minor revisions of data in this report. Please check the online version at <www.aihw.gov.au> for any amendments. -
Etiology, Classification, and Treatment of Urticaria
CONTINUING MEDICAL EDUCATION Etiology, Classification, and Treatment of Urticaria Kjetil Kristoffer Guldbakke, MD; Amor Khachemoune, MD, CWS GOAL To understand urticaria to better manage patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Discuss the clinical classification of urticaria. 2. Recognize how to diagnose urticaria. 3. Identify treatment options. CME Test on page 50. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine, the ACCME to provide continuing medical edu- Albert Einstein College of Medicine. Review date: cation for physicians. December 2006. Albert Einstein College of Medicine designates This activity has been planned and imple- this educational activity for a maximum of 1 AMA mented in accordance with the Essential Areas PRA Category 1 CreditTM. Physicians should only and Policies of the Accreditation Council for claim credit commensurate with the extent of their Continuing Medical Education through the participation in the activity. joint sponsorship of Albert Einstein College of This activity has been planned and produced in Medicine and Quadrant HealthCom, Inc. Albert accordance with ACCME Essentials. Drs. Guldbakke and Khachemoune report no conflict of interest. The authors discuss off-label use of colchi- cine, cyclophosphamide, cyclosporine, dapsone, intravenous immunoglobulin, methotrexate, montelukast sodium, nifedipine, plasmapheresis, rofecoxib, sulfasalazine, tacrolimus, thyroxine, and zafirlukast. Dr. Fisher reports no conflict of interest. Urticaria is among the most common skin dis- autoimmune mechanisms are now recognized as a eases. It can be acute, chronic, mediated by a cause of chronic urticaria. A search of the PubMed physical stimulus, or related to contact with an database (US National Library of Medicine) for urticant. -
Local Heat Urticaria
Volume 23 Number 12 | December 2017 Dermatology Online Journal || Case Presentation DOJ 23 (12): 10 Local heat urticaria Forrest White MD, Gabriela Cobos MD, and Nicholas A Soter MD Affiliations: 1 New York University Langone Health, New York Abstract PHYSICAL EXAMINATION: A brisk, mechanical stroke elicited a linear wheal. Five minutes after exposure We present a 38-year-old woman with local heat to hot water, she developed well-demarcated, urticaria confirmed by heat provocation testing. Heat erythematous blanching wheals that covered the urticaria is a rare form of physical urticaria that is distal forearm and entire hand. triggered by exposure to a heat source, such as hot water or sunlight. Although it is commonly localized Conclusion and immediate, generalized and delayed onset forms Physical or inducible urticarias are a group of exist. Treatment options include antihistamines urticarias that are triggered by various external and heat desensitization. A brisk, mechanical stroke physical stimuli, such as mechanical stimuli, pressure, elicited a linear wheal. Five minutes after exposure cold, light, or temperature change. Urticarias due to hot water, she developed well-demarcated, to temperature change include heat urticaria (HU), erythematous blanching wheals that covered the cholinergic urticaria, and cold urticaria. distal forearm and entire hand. HU is a rare form of chronic inducible urticaria, with Keywords: urticaria, local heat urticaria, physical approximately 60 reported cases [1]. In HU, contact urticaria with a heat source such as hot water, sunlight, hot air, radiant heat, or hot objects results in wheal formation Introduction HISTORY: A 38-year-old woman presented to the Skin and Cancer Unit for the evaluation of recurrent, intensely pruritic eruptions that were precipitated by exposure to heat, which included hot water and sunlight. -
Consensus Recommendations for National and State Poisoning Surveillance
Consensus Recommendations for National and State Poisoning Surveillance REPORT FROM THE INJURY SURVEILLANCE WORKGROUP (ISW7) April 2012 Table of Contents FOREWORD 3 EXECUTIVE SUMMARY 4 Key products of the ISW7 include: 4 INTRODUCTION 6 Public Health Burden of Poisoning 7 CONCEPTUAL DEFINITIONS OF POISONING AND DRUG 9 Poisoning 9 Drug 10 OPERATIONAL DEFINITIONS OF POISONING AND DRUG POISONING 12 Description of the Poisoning Matrix for ICD-9-CM Coded Morbidity Data 12 Description of Poisoning Matrix for ICD-10 Coded Mortality Data 15 Operational Definitions for Other Major Data Sources 18 INVENTORY OF POISONING DATA SOURCES 20 GENERAL CONSIDERATIONS AND RECOMMENDATIONS FOR IMPROVING POISONING SURVEILLANCE 21 General considerations 21 Recommendations for proposed drug poisoning indicators for surveillance for state and local jurisdictions 21 Considerations for further sub-categorizations of indicators 24 RECOMMENDATIONS TO IMPROVE SURVEILLANCE AT THE STATE OR LOCAL LEVEL 25 Mortality surveillance 25 Morbidity surveillance 25 RECOMMENDATIONS TO IMPROVE SURVEILLANCE AT THE NATIONAL LEVEL 27 REFERENCES 29 APPENDICES 31 Appendix A: Detailed Description of Data Sources 32 Appendix B1: Poisoning Matrix for ICD-10 Coded Mortality Data 94 Appendix B2: SAS Programs for Poisoning Matrix for ICD-10 Coded Mortality Data 99 Appendix C1: Poisoning Matrix for ICD-9-CM Coded Morbidity Data 101 Appendix C2: SAS Programs for Poisoning Matrix for ICD-9-CM Coded Morbidity Data 106 Appendix D: List of ISW7 Workgroup Members 107 Consensus Recommendations for National and State Poisoning Surveillance 1 Methodology for this report: The Injury Surveillance Workgroup 7 worked from July 2009 through April 2012 using monthly conference calls, and more frequently through small subgroup calls, to develop this report. -
Antihistamines in the Treatment of Chronic Urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 a Del Cuvillo,6 J Mullol,7 J Sastre,8 a Valero5
Antihistamines in the treatment of chronic urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 A del Cuvillo,6 J Mullol,7 J Sastre,8 A Valero5 1 Service of Allergy, Hospital de Basurto, Bilbao, Spain 2 Department of Allergology, Clínica Universitaria de Navarra, Pamplona, Spain 3 Allergy Unit, Hospital La Plana, Villarreal (Castellón), Spain 4 Service of Immunoallergy, Hospital Clínico, Salamanca, Spain 5 Allergy Unit, Service of Pneumology and Respiratory Allergy, Hospital Clínic (ICT), Barcelona, Spain 6 Clínica Dr. Lobatón, Cádiz, Spain 7 Rhinology Unit, ENT Service (ICEMEQ), Hospital Clínic, Barcelona, Spain 8 Service of Allergy, Fundación Jiménez Díaz, Madrid, Spain ■ Summary Chronic urticaria is highly prevalent in the general population, and while there are multiple treatments for the disorder, the results obtained are not completely satisfactory. The second-generation H1 antihistamines remain the symptomatic treatment option of choice. Depending on the different pharmacokinetics and H1 receptor affi nity of each drug substance, different concentrations in skin can be expected, together with different effi cacy in relation to the histamine-induced wheal inhibition test - though this does not necessarily have repercussions upon clinical response. The antiinfl ammatory properties of the H1 antihistamines could be of relevance in chronic urticaria, though it is not clear to what degree they infl uence the fi nal therapeutic result. Before moving on to another therapeutic level, the advisability of antihistamine dose escalation should be considered, involving increments even above those approved in the Summary of Product Characteristics. Physical urticaria, when manifesting isolatedly, tends to respond well to H1 antihistamines, with the exception of genuine solar urticaria and delayed pressure urticaria. -
Urticaria and Angioedema
Skin tests may be performed to determine the substance that you are allergic to. Routine blood tests are done to determine if a systemic illness is present. Urticaria and Treatment for Urticaria and Angioedema Angioedema • The best treatment for hives and angioedema is to identify and remove the trigger, but this is often a hard task. • Antihistamines block the effect of histamine, and can reduce itching and rash in most cases. Antihistamines may be needed for as long as the urticaria persists. Reports of serious side effects of antihistamines are very rare. Allergy Centre • A low histamine diet can help to reduce exogenous histamine derived from foods, which helps in some cases. To find out more about a low histamine diet, please contact our dietitian. 過敏病科中心 • Oral corticosteroids may be prescribed. • For a severe hives or angioedema outbreak, an injection of adrenaline or a steroid medication may be needed. • Other immunosuppressant such as cyclosporin may be beneficial in severe cases for long term control. For enquiries and appointments, Tips to Manage Urticaria and please contact us at: Angioedema Allergy Centre • Avoid hot water; use lukewarm water 9/F, Li Shu Pui Block • Use gentle, mild soap Hong Kong Sanatorium & Hospital 2 Village Road, Happy Valley, Hong Kong • Apply cool compresses or wet cloths to the affected areas Tel: 2835 8430 Fax: 2892 7565 • Try to work and sleep in a cool room Email: [email protected] • Wear loose-fitting lightweight clothes Service Hours • Avoid foods that are fermented or high in colorings Mon, Tue, Thu & Fri : 9:00 am – 6:00 pm ALC.038I.H/E-03-102017 and preservatives Wed & Sat : 9:00 am – 1:00 pm 過敏病科中心 • Keep a food dairy to identify any specific food triggers Closed on Sundays and Public Holidays www.hksh-hospital.com Allergy Centre A member of HKSH Medical Group © Hong Kong Sanatorium & Hospital Limited. -
10 Chronic Urticaria As an Autoimmune Disease
10 Chronic Urticaria as an Autoimmune Disease Michihiro Hide, Malcolm W. Greaves Introduction Urticaria is conventionally classified as acute, intermittent and chronic (Grea- ves 2000a). Acute urticaria which frequently involves an IgE-mediated im- munological mechanism, is common, its causes often recognised by the patient, and will not be considered further. Intermittent urticaria – frequent bouts of unexplained urticaria at intervals of weeks or months – will be dis- cussed here on the same basis as ‘ordinary’ chronic urticaria. The latter is conventionally defined as the occurrence of daily or almost daily whealing for at least six weeks. The etiology of chronic urticaria is usually obscure. The different clinical varieties of chronic urticaria will be briefly considered here, and attention will be devoted to a newly emerged entity – autoimmune chronic urticaria, since establishing this diagnosis has conceptual, prognostic and the- rapeutic implications. Contact urticaria and angioedema without urticaria will not be dealt with in this account. Classification of Chronic Urticaria The clinical subtypes of chronic urticaria are illustrated in the pie-chart of Fig. 1. The frequency of these subtypes is based upon the authors’ experience at the St John’s Institute of Dermatology in UK. Whilst there may well be mi- nor differences, it is likely that the frequency distribution of these subtypes will be essentially similar in most centres in Europe and North America (Grea- ves 1995, 2000b). However, our experience suggests that the incidence of angioedema, especially that complicated by ordinary chronic urticaria is sub- stantially lower in Japan and south Asian countries (unpublished observation). 310 Michihiro Hide and Malcolm W. -
Urticaria and Angioedema
Urticaria and Angioedema This guideline, developed by Robbie Pesek, MD and Allison Burbank, MD, in collaboration with the ANGELS team, on July 23, 2013, is a significantly revised version of the guideline originally developed by Jeremy Bufford, MD. Last reviewed by Robbie Pesek, MD September 14, 2016. Key Points Urticaria and angioedema are common problems and can be caused by both allergic and non- allergic mechanisms. Prompt diagnosis of hereditary angioedema (HAE) is important to prevent morbidity and mortality. Several new therapeutic options are now available. Patients with urticaria and/or angioedema should be referred to an allergist/immunologist for symptoms that are difficult to control, suspicion of HAE, or to rule out suspected allergic triggers. Definition, Assessment, and Diagnosis Definitions Urticaria is a superficial skin reaction consisting of erythematous, raised, blanching, well- circumscribed or confluent pruritic, edematous wheals, often with reflex erythema.1-3 Urticarial lesions are typically pruritic, and wax/wane with resolution of individual lesions within 24 hours. Angioedema is localized swelling of deep dermal, subcutaneous, or submucosal tissue resulting from similar vascular changes that contribute to urticaria.1,2 Angioedema may be pruritic and/or painful and can last for 2-3 days depending on etiology.3 1 Urticaria alone occurs in 50% of patients and is associated with angioedema in 40% of patients. Isolated angioedema occurs in 10% of patients.1,2 Hereditary angioedema (HAE) is a disorder involving defects in complement, coagulation, kinin, and fibrinolytic pathways that results in recurrent episodes of angioedema without urticaria, usually affecting the skin, upper airway, and gastrointestinal tract.4 In children, acute urticaria is more common than chronic forms.